Traditional Chinese medicine composition for treating infantile adenoid hypertrophy

Through the use of traditional Chinese medicine compositions such as Xinyi, Guizhi, and Astragalus, the problem of alleviating the symptoms of adenoid hypertrophy in children is solved, and the effect of effectively inhibiting adenoid hyperplasia and inflammation is achieved, and the symptoms is reduced without toxic side effects. It is suitable for different Dosage form application.

CN118924823APending Publication Date: 2024-11-12HUBEI PROVINCIAL HOSPITAL OF TRADITIONAL CHINESE MEDICINE (AFFILIATED HOSPITAL OF HUBEI UNIV OF TRADITIONAL CHINESE MEDICINE HUBEI INST OF TRADITIONAL CHINESE MEDICINE)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411010440.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-26
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The prior art has unknown effects and possible immune function damage caused by surgery in the treatment of adenoid hypertrophy in children, and the development of traditional Chinese medicine therapy is insufficient, which cannot effectively alleviate the symptoms of nasal congestion, snoring, mouth opening and breathing caused by adenoid hypertrophy.

Method used

Provided a traditional Chinese medicine composition, containing cinnamon twig, astragalus, asparagus, asarum, xanthus, mulberry leaves, pepper, perilla leaves and Polygonum multiflorum vine, which can dispel wind and disperse evil, dispel menstruation and revitalize the meridians and revitalize the meridians and nourish the lungs and spleen. , relieve adenoid hyperplasia and relieve symptoms.

Benefits of technology

This traditional Chinese medicine composition can effectively inhibit adenoid inflammation, reduce the range of blockage, shorten the course of the disease, reduce or inhibit the hyperplasia of adenoids, relieve symptoms such as snoring, mouth opening and breathing, and have no adverse reactions. It is suitable for different dosage forms.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924823A_ABST
    Figure CN118924823A_ABST
Patent Text Reader

Abstract

The invention discloses a traditional Chinese medicine composition for treating infantile adenoid hypertrophy. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 9-12 parts of flos magnoliae, 9-12 parts of cassia twig, 9-12 parts of radix astragali, 3-6 parts of herba asari, 9-12 parts of fructus xanthii, 9-12 parts of folium mori, 3-6 parts of pericarpium zanthoxyli, 3-6 parts of folium perillae and 12-15 parts of caulis polygoni multiflori. In the formula, cassia twig can dispel wind evil, dredge meridians and strengthen yang qi; the vine of multiflower knotweed can promote meridians and collaterals and promote blood circulation and is a monarch drug; the perilla leaf can resist inflammation and relieve pain; mulberry leaves can clear lung meridian and wind heat on the surface, and effectively inhibit inflammation of adenoid bodies and surrounding tissues of the adenoid bodies; the flos magnoliae can disperse wind-cold and relieve stuffy nose; the asarum can open lung qi and relieve nasal obstruction; the cocklebur fruit can dispel wind evil and dredge nasal orifices and is used as a ministerial drug; the Chinese prickly ash can promote blood circulation, soften hardness and dissipate stagnation, and can help the vine of multiflower knotweed to promote blood circulation and remove meridian obstruction, the astragalus membranaceus can tonify qi of spleen and lung, and the cassia twig can tonify qi and raise yang. The whole formula has the effects of dispelling wind and eliminating evil, dredging channels and activating collaterals and tonifying lung and spleen, and can relieve or inhibit adenoid hyperplasia, reduce the blockage range and relieve symptoms such as snoring and mouth breathing.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating adenoids hypertrophy in children. Background Art

[0002] Adenoids hypertrophy is a pathological hypertrophy disease that occurs after an inflammatory response stimulates the adenoids. It is a common disease in childhood. The clinical manifestations of the disease include nasal congestion, snoring, mouth breathing and other clinical symptoms, which affect the growth and development of children. Some children with severe adenoids hypertrophy can undergo surgical resection, but the surgery has unknown effects on the child's development, parents' acceptance is low, and the surgery may cause damage to the child's immune function and decreased resistance. Traditional Chinese medicine, as a more reliable alternative therapy, has played a good role in the treatment of this disease and is relatively safe. Therefore, it is necessary to develop a traditional Chinese medicine formula that can treat adenoids hypertrophy in children. Summary of the invention

[0003] The purpose of the present invention is to provide a Chinese medicine composition for treating adenoids hypertrophy in children, which can reduce or inhibit the proliferation of adenoids, reduce the range of blockage, and relieve symptoms such as snoring and mouth breathing, in view of the above problems existing in the prior art.

[0004] To achieve the above objectives, the technical solution of the present invention is as follows:

[0005] A traditional Chinese medicine composition for treating adenoids hypertrophy in children. The raw material composition and weight ratio of the traditional Chinese medicine composition are: 9-12 parts of magnolia, 9-12 parts of cassia twig, 9-12 parts of astragalus, 3-6 parts of asarum, 9-12 parts of xanthium sibiricum, 9-12 parts of mulberry leaf, 3-6 parts of zanthoxylum, 3-6 parts of perilla leaf, and 12-15 parts of Polygonum multiflorum.

[0006] The raw material composition and weight ratio of the traditional Chinese medicine composition are: 10 parts of magnolia, 10 parts of cassia twig, 10 parts of astragalus, 6 parts of asarum, 10 parts of xanthium sibiricum, 10 parts of mulberry leaf, 5 parts of zanthoxylum, 5 parts of perilla leaf, and 15 parts of radix polygoni multiflori.

[0007] Compared with the prior art, the present invention has the following beneficial effects:

[0008] The invention discloses a Chinese medicine composition for treating adenoid hypertrophy in children. The raw materials of the Chinese medicine composition are as follows in weight: 9-12 parts of magnolia, 9-12 parts of cassia twig, 9-12 parts of astragalus, 3-6 parts of asarum, 9-12 parts of xanthium sibiricum, 9-12 parts of mulberry leaf, 3-6 parts of prickly ash, 3-6 parts of perilla leaf and 12-15 parts of radix polygoni multiflori. In the prescription, cassia twig dispels wind evil, dredges meridians and helps yang energy; radix polygoni multiflori can "circulate meridians and dredge blood vessels", dispel wind and dredge meridians, and both are monarch drugs; perilla leaf is a way to release evil energy. It is an important medicine with anti-inflammatory, analgesic and anti-pathogen effects. Mulberry leaves can clear the lung meridian and wind-heat on the surface, effectively inhibit inflammation of adenoids and surrounding tissues. Magnolia can dispel wind and cold, clear the nasal passages, enter the lungs and go up to the nose, and is an important medicine for clearing the nasal passages. Asarum can "open the lung qi and clear nasal congestion". Xanthium sibiricum is pungent and warm, rises and floats upward, is good at dispersing wind evil, clears the nasal passages, and is a ministerial medicine. Zanthoxylum bungeanum can clear blood vessels, soften and disperse nodules, remove blood stasis and promote new growth, and can help Polygonum multiflorum to activate blood circulation and dredge collaterals. Astragalus enters the lung and spleen meridians, is good at tonifying the spleen and lung qi, and can help cinnamon twigs to replenish qi and raise yang. The whole prescription has the effects of dispelling wind and evil, dredging meridians and activating collaterals, and tonifying the lungs and spleen. It has good clinical application effects and no adverse reactions. It can shorten the course of the disease, reduce or inhibit the hyperplasia of adenoids, reduce the scope of blockage, and relieve symptoms such as snoring and mouth breathing. BRIEF DESCRIPTION OF THE DRAWINGS

[0009] Figure 1 This is the clinical trial process of the present invention. DETAILED DESCRIPTION

[0010] The present invention is further described in detail below in conjunction with specific implementations and drawings.

[0011] A traditional Chinese medicine composition for treating adenoids hypertrophy in children. The raw material composition and weight ratio of the traditional Chinese medicine composition are: 9-12 parts of magnolia, 9-12 parts of cassia twig, 9-12 parts of astragalus, 3-6 parts of asarum, 9-12 parts of xanthium sibiricum, 9-12 parts of mulberry leaf, 3-6 parts of zanthoxylum, 3-6 parts of perilla leaf, and 12-15 parts of Polygonum multiflorum.

[0012] The raw material composition and weight ratio of the traditional Chinese medicine composition are: 10 parts of magnolia, 10 parts of cassia twig, 10 parts of astragalus, 6 parts of asarum, 10 parts of xanthium sibiricum, 10 parts of mulberry leaf, 5 parts of zanthoxylum, 5 parts of perilla leaf, and 15 parts of radix polygoni multiflori.

[0013] The principle of the present invention is described as follows:

[0014] The traditional treatment concept of children's adenoids hypertrophy is that due to the physiological and pathological characteristics of children, children's internal organs are delicate, their physical and qi are not full, and they are easily invaded by evil. Wind evil and cold and heat evil qi combine to block the lungs, causing the lungs to fail to descend, and the body fluids are abnormally transported and form phlegm, which blocks the nasopharyngeal airway and causes this disease. The Chinese medicine composition of the present invention is a clinical experience prescription. The inventor concludes that children's adenoids hypertrophy belongs to the deficiency of the root and the excess of the superficial. This prescription adds Chinese medicine for tonifying the lungs and spleen while removing evil, so that the evil is removed without hurting the body; children's adenoids hypertrophy is often accompanied by rhinitis. This prescription uses drugs for clearing the nasal passages, which can effectively relieve nasal congestion, runny nose, mouth breathing and other symptoms; hypertrophic adenoids are tangible evil, evil qi blocks the collaterals, and qi and blood are blocked, so they need to be cleared and dispersed, so this prescription uses drugs for activating meridians and blood circulation to effectively inhibit inflammation of adenoids and their surrounding tissues.

[0015] The Chinese medicine composition of the present invention has a novel formula, is low in cost, has good efficacy, has no toxic side effects, and is highly accepted by children, and is suitable for the treatment of adenoid hypertrophy. The Chinese medicine composition of the present invention is prepared into different dosage forms according to the patient's condition, such as external lotion and oral decoction. The external lotion has the advantages of simple operation and reliable efficacy. The drug acts on the skin, which can reduce the risk of being damaged by gastric acid, protect the gastrointestinal tract, avoid the first-pass effect of the liver, and reduce adverse drug reactions. However, it is not suitable for patients who are allergic to external lotions or have large-area ulcers on the skin and open wounds on the whole body. At this time, it can be changed to oral decoction to ensure the therapeutic effect.

[0016] Embodiment 1:

[0017] A Chinese medicine composition for treating adenoid hypertrophy in children, wherein the raw material composition and weight ratio of the Chinese medicine composition are: 10g magnolia, 10g cassia twig, 10g astragalus, 6g asarum, 10g xanthium, 10g mulberry leaf, 5g prickly ash, 5g perilla leaf, 15g Polygonum multiflorum. Pour the above raw materials into a decoction machine according to the required proportion, add 2000-2500mL cold water and soak for about 30min, first boil with high heat until boiling, then simmer with low heat for 20min, and cool to 50°C. The prepared Chinese medicine soup can be used for both full body scrubbing and foot soaking.

[0018] Embodiment 2:

[0019] The difference from Example 1 is that:

[0020] The raw material composition and weight ratio of the traditional Chinese medicine composition for treating adenoids hypertrophy in children are: 9g magnolia, 9g cassia twig, 9g astragalus, 3g asarum, 9g xanthium, 9g mulberry leaf, 3g zanthoxylum, 3g perilla leaf, and 12g Polygonum multiflorum.

[0021] Embodiment 3:

[0022] The difference from Example 1 is that:

[0023] The raw material composition and weight ratio of the traditional Chinese medicine composition for treating adenoids hypertrophy in children are: 12g magnolia, 12g cassia twig, 12g astragalus, 6g asarum, 12g xanthium, 12g mulberry leaf, 6g zanthoxylum, 6g perilla leaf, and 15g Polygonum multiflorum.

[0024] The beneficial effects of the present invention are demonstrated by clinical trials or specific pharmacodynamic tests. Figure 1 shown.

[0025] Materials and Methods

[0026] 1. General Information

[0027] Case source: 86 children with adenoids hypertrophy admitted to the Pediatric Outpatient Department of Hubei Provincial Hospital of Traditional Chinese Medicine from December 2021 to December 2022 were selected and randomly divided into a control group and a treatment group of 43 cases in each group. Among them, 26 cases were treated for 1 course of treatment, 12 cases were treated for 2 courses of treatment, and 5 cases were treated for 3 courses of treatment.

[0028] 2. Observation indicators

[0029] The main clinical symptoms include nasal congestion, mouth breathing, and snoring;

[0030] Adenoids volume grading: Grade I: adenoids block the posterior nares ≤ 25%; Grade II: adenoids block the posterior nares 26%-50%; Grade III: adenoids block the posterior nares 51-75%; Grade IV: adenoids block the posterior nares > 75%.

[0031] 3. Treatment Methods

[0032] Control group: treated with mometasone furoate nasal spray combined with montelukast sodium chewable tablets.

[0033] Treatment group: The patients were given the Chinese medicine composition described in Example 1; one dose per day, and one month was one course of treatment.

[0034] 4. Efficacy evaluation criteria

[0035] 1. Evaluation criteria for syndrome efficacy

[0036] Refer to the efficacy judgment standard of the "Guidelines for Clinical Research of New Chinese Medicines" and use the nimodipine method to calculate. Efficacy index = (pre-treatment score - post-treatment score) / pre-treatment score * 100%

[0037] Clinical recovery: symptoms and signs disappear or almost disappear, and syndrome score decreases by ≥95%;

[0038] Markedly effective: symptoms and signs are significantly improved, with syndrome score ≥70% but <95%;

[0039] Effective: symptoms and signs are improved, and the syndrome score is reduced by ≥30% but <70%;

[0040] Ineffective: Symptoms and signs have no significant improvement, or even worsen, and the syndrome score is less than 30%;

[0041] (II) Scoring criteria for main indicators

[0042] The degree of nasal congestion: persistent nasal congestion and the need to breathe through the mouth for more than 2 hours and affecting sleep is scored 8 points; persistent nasal congestion for less than 2 hours and sometimes the need to breathe through the mouth is scored 6 points; persistent nasal congestion for less than 2 hours but not affecting sleep is scored 4 points; intermittent nasal congestion but not affecting sleep is scored 2 points; no poor ventilation is scored 0 points.

[0043] Snoring degree: persistent snoring for more than 2 hours and affecting sleep, sometimes with breathing interruptions, is scored 8 points; persistent snoring for more than 2 hours does not affect sleep, is scored 6 points; persistent snoring for less than 2 hours is scored 4 points; intermittent snoring but does not affect sleep is scored 2 points; no snoring is scored 0 points.

[0044] Mouth breathing degree: If the patient persists with mouth breathing for more than 2 hours and is unable to lie flat after waking up due to suffocation, it is scored 8 points; if the patient persists with mouth breathing for more than 2 hours and sometimes wakes up due to suffocation or startling, it is scored 6 points; if the patient persists with mouth breathing for less than 2 hours, it is scored 4 points; if the patient intermittently breathes with mouth breathing and does not affect sleep, it is scored 2 points; if the patient does not breathe with mouth breathing, it is scored 0 points.

[0045] Adenoid volume: grade IV is scored as 6 points; grade III is scored as 4 points; grade II is scored as 2 points; grade I is scored as 0 points.

[0046] 5. Comparison of efficacy results

[0047] Table 1 Comparison of efficacy between the control group and the treatment group

[0048] Group get well Significant effect efficient invalid Total Effectiveness Treatment Group 12 14 11 6 86% Control group 6 12 14 11 74.4%

[0049] Table 2 Evaluation of main symptom scores before and after different courses of treatment

[0050] Treatment Number of cases get well Significant effect Improvement invalid Cure rate Total Effectiveness 1 course of treatment 28 9 8 6 5 60.7% 82.1% 2 courses 11 2 4 4 1 54.5% 90.9% 3 courses 4 1 2 1 0 75% 100%

[0051] As can be seen from Table 1, the efficacy of the Chinese medicine composition of the present invention in treating adenoid hypertrophy is better than that of the control group, and can effectively improve the clinical symptoms of children and reduce the volume of adenoids. As can be seen from Table 2, most children's symptoms were significantly improved after one course of treatment, and as time went on, the cure rate and the effective rate showed an upward trend, and no adverse reactions occurred.

[0052] Typical case 1:

[0053] Huang, 7 years old, was diagnosed with adenoids hypertrophy for more than three months, with nasal congestion, snoring, and A|N of 0.7. He used the external lotion prepared in Example 1 to scrub his whole body once a day. After one course of treatment, he occasionally had nasal congestion, less snoring, less frequent attacks, and no mouth breathing. It can be seen that the clinical symptoms were significantly alleviated, and A|N dropped to 0.65. After three courses of treatment, A|N dropped to 0.4, and the symptoms basically disappeared.

[0054] Typical case 2:

[0055] Yu, 10 years old, was diagnosed with adenoids hypertrophy for more than six months, with moderate nasal congestion, but could fall asleep, with mild mouth opening, runny nose, sneezing, and A|N of 0.76. He used the external lotion prepared in Example 1 to scrub his whole body once a day. After one course of treatment, A|N dropped to 0.5, with no nasal congestion, mild snoring, each time lasting for a short time, and occasional mouth breathing. It can be seen that the clinical symptoms were significantly relieved. After three courses of treatment, A|N dropped to 0.3, and the symptoms basically disappeared.

[0056] Typical case three:

[0057] He, 6 years old, snored, mouth breathing for half a year, severe mouth opening, poor appetite, A|N of 0.72, daily use of the external lotion prepared in Example 1, foot bath, once a day; after one course of treatment, A|N dropped to 0.6, after three courses of treatment, A|N dropped to 0.35, the symptoms basically disappeared.

Claims

1. A Chinese medicine composition for treating adenoids hypertrophy in children, Features: The raw material composition and weight ratio of the traditional Chinese medicine composition are: 9-12 parts of magnolia, 9-12 parts of cassia twig, 9-12 parts of astragalus, 3-6 parts of asarum, 9-12 parts of xanthium sibiricum, 9-12 parts of mulberry leaf, 3-6 parts of zanthoxylum, 3-6 parts of perilla leaf, and 12-15 parts of Polygonum multiflorum.

2. A Chinese medicine composition for treating adenoids hypertrophy in children according to claim 1, Features: The raw material composition and weight ratio of the traditional Chinese medicine composition are: 10 parts of magnolia, 10 parts of cassia twig, 10 parts of astragalus, 6 parts of asarum, 10 parts of xanthium sibiricum, 10 parts of mulberry leaf, 5 parts of zanthoxylum, 5 parts of perilla leaf, and 15 parts of radix polygoni multiflori.